Creating Drug Standards

On the one hand this, Congress Weighs Drug Comparisons, sounds reasonable. On the other, it illustrates the problem when the someone else pays for what one receives.

And, this is also the kind of thing that HMOs have tried to do and been villified for it. (That is to say, cost/benefit analysis in terms of determing what will be paid for and what will not).

The bottom line is that more care is managed, whether by private companies or the government, choice is curtailed.